Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

14/10 Earnings release - Q2 2026

More about the company

17/09	Theraclion SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
16/09	Theraclion widens its operating loss in the first half

Market Cap	5.19Cr 5.95Cr 4.9Cr 4.45Cr 8.34Cr 571.19Cr 8.37Cr 59Cr 23Cr 290.4Cr 22Cr 22Cr 934.39Cr	P/E 2024	-2.66x	P/E 2025	-6.33x
Enterprise Value	5.98Cr 6.85Cr 5.64Cr 5.12Cr 9.6Cr 657.59Cr 9.64Cr 68Cr 26Cr 334.33Cr 26Cr 25Cr 1.08TCr	EV / Sales 2024	22.5x	EV / Sales 2025	55.4x
Free-Float	31.92%	Yield 2024 *	-	Yield 2025	-

17/09	Theraclion SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
16/09	Theraclion widens its operating loss in the first half
24/07	Theraclion SA Reports Consolidated Revenue Results for the First Half Ended June 30, 2026	CI
09/07	Theraclion Announces Board Changes	CI
09/07	Theraclion Appoints New Chairman	MT
19/06	Claude Lenoir appointed interim chairman of Theraclion
19/06	Theraclion Chairman Steps Down; Interim Successor Named	MT
18/06	Theraclion Announces Board Changes	CI
09/06	Theraclion Secures AMA CPT Editorial Panel Approval For New Category III CPT Code For Sonovein	CI
05/06	Theraclion deploys first Sonovein system in China
05/06	Theraclion JV Deploys Sonovein System at Chinese Hospital	MT
05/06	Theraclion Announces First Clinical Deployment Of Sonovein In Hainan, China	CI
05/06	Theraclion Deploys Sonovein System At Boao Super Hospital in Hainan Province	CI

16/09	2026 Half-Year Results: Theraclion Prepares for a New Stage in Its Development	BU
23/07	Theraclion Initiates Its Commercial Momentum in the First Half of 2026	BU
15/07	Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL	BU
09/07	Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors	BU
18/06	Theraclion Announces the Evolution of Its Board of Directors	BU

16/09	Theraclion creuse sa perte d'exploitation au 1er semestre
16/09	RÉSULTATS SEMESTRIELS 2026 : THERACLION SE PRÉPARE À UNE NOUVELLE ÉTAPE DE SON DÉVELOPPEMENT
23/07	THERACLION AMORCE SA DYNAMIQUE COMMERCIALE AU PREMIER SEMESTRE 2026
15/07	Theraclion: BILAN DU PREMIER SEMESTRE 2026 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LE CRÉDIT INDUSTRIEL ET COMMERCIAL
09/07	Vincent Gardès prend la présidence du conseil d'administration de Theraclion

THERACLION N Share Price Euronext Paris

Stocks

FR0010120402

Advanced Medical Equipment & Technology

Valuation: THERACLION N

Latest news: THERACLION N

Press Releases: THERACLION N

News in other languages: THERACLION N

Managers and Directors: THERACLION N

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Manager	Title	Age	Since
Martin Deterre CEO	Chief Executive Officer	-	24/05/2023
Julie Veisseire DFI	Director of Finance/CFO	-	-
Alexandra Rocher COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Mehdi El Glaoui BRD	Director/Board Member	-	22/06/2021
Cédric Bellanger BRD	Director/Board Member	-	28/01/2022
Lijuan Deng BRD	Director/Board Member	-	29/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERMO FISHER SCIENTIFIC, INC.	-1.04%	+6.83%	+35.84%	+28.05%	24TCr
DANAHER CORPORATION	-0.32%	+5.83%	+9.58%	-17.01%	15TCr
INTUITIVE SURGICAL, INC.	+2.55%	+6.55%	-10.35%	+31.26%	14TCr
BOSTON SCIENTIFIC CORPORATION	-0.48%	+0.84%	-55.70%	-18.27%	6.28TCr
EDWARDS LIFESCIENCES CORPORATION	+0.01%	+4.61%	+18.61%	+20.87%	5.09TCr
SIEMENS HEALTHINEERS AG	-1.69%	-1.20%	-19.89%	-15.39%	4.82TCr
AGILENT TECHNOLOGIES, INC.	+0.08%	+6.49%	+23.87%	+39.32%	4.41TCr
WATERS CORPORATION	-1.88%	+3.25%	+40.14%	+53.16%	4.14TCr
ILLUMINA, INC.	-2.27%	+16.07%	+133.21%	+70.51%	3.62TCr
Average	-0.56%	+6.42%	+19.48%	+21.39%	9.03TCr
Weighted average by Cap.	-0.26%	+6.14%	+15.57%	+17.51%

	2024	2025
Net sales	8L 10L 8L 7L 13.34L 9.14Cr 13.39L 93.9L 36.24L 4.64Cr 35.76L 34.97L 15Cr	7L 7L 6L 6L 10.47L 7.17Cr 10.52L 73.74L 28.46L 3.65Cr 28.09L 27.46L 12Cr
Net income	-57.57L -66.02L -54.36L -49.36L -92.49L -63Cr -92.87L -6.51Cr -2.51Cr -32Cr -2.48Cr -2.43Cr -103.64Cr	-56.9L -65.25L -53.73L -48.79L -91.41L -63Cr -91.79L -6.44Cr -2.48Cr -32Cr -2.45Cr -2.4Cr -102.43Cr
Net Debt	34.11L 39.11L 32.21L 29.24L 54.79L 38Cr 55.02L 3.86Cr 1.49Cr 19Cr 1.47Cr 1.44Cr 61Cr	78.52L 90.05L 74.14L 67.33L 1.26Cr 86Cr 1.27Cr 8.88Cr 3.43Cr 44Cr 3.38Cr 3.31Cr 141.35Cr

End-of-day quote Euronext Paris
- ^EUR	-